-
France set for a lunar eclipse later this week
Second eclipse of month will bring spectacular colours to moon – but you will need to wake up early to see them
-
Centre-left Raphaël Glucksmann announces French presidency bid
Politician is popular among Socialists but struggles with his image as a member of the intellectual elite who is out of touch with the everyday challenges of French people
-
How Americans can stay in France beyond the EU's 90/180 days rule
Old France-US deal lets some visitors stay for longer
France’s medical cannabis trial sparks market battle
Tensions are rising between European companies, Canadian firms and French producers as France prepares to allow imports of cannabis-based medical treatments on a trial basis later this year.
The trial is set to last two years from September, with more than 3,000 patients in France expected to be the first to receive the new drugs.
Drug safety agency ANSM confirmed that it would be open to authorising “foreign products”, and said that it had already “auditioned” seven companies last year.
Several Canadian companies are already seeking to enter the market, along with Dutch firm Bedrocan and British group Emmac Life Sciences.
Stay informed:
Sign up to our free weekly e-newsletter
Subscribe to access all our online articles and receive our printed monthly newspaper The Connexion at your home. News analysis, features and practical help for English-speakers in France
